Skip to main content

CONMED Corporation (CNMD)

New York Stock Exchange Healthcare Medical - DevicesView data quality →
57.6Fair

ValueMarkers Composite Index

Top 66%#15,049 of 44,707
Undervalued

76% below intrinsic value ($141)

UndervaluedFair ValueOvervalued
Piotroski
6/9
Neutral
Beneish
-2.67
Low Risk
Altman
1.77
Distress
DCF Value
$141
Undervalued
ROIC
3.4%
Low
P/E
25.3
Growth
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

CONMED Corporation (CNMD) — VMCI valuation read

CNMD screens at VMCI 58/100, a 8-point gap above the Healthcare sector median (50). For a mid-cap CONMED Corporation share, that placement says the multi-pillar composite is cheaper or higher quality than the typical peer on a like-for-like basis.

CNMD has logged no Form 4 insider activity over the trailing 30 days. The tape reads neither bullish nor bearish on insider conviction. The next signal sits with the 10-Q schedule and the analyst calendar.

**Investor frame.** Value: CNMD trades at 20.0x earnings, 11% above the Healthcare median of 18.0x, while EV/EBITDA prints 9.0x against 12.0x for the Healthcare group. Quality: ROIC of 8.0% trails the Healthcare median (10.0%) by 2.0pp, the cleanest like-for-like comparison on capital efficiency. Risk: net debt to EBITDA of -1.8x leaves covenant headroom, which sets the rate-cycle exposure for CONMED Corporation.

CNMD rose 3.8% over the trailing 7 days, with a -6.4% read on a 30-day basis.

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

CEO: Patrick J. Beyer3,900 employeesUSwww.conmed.com

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in CNMD’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.